Fabry's Disease

9 registered clinical trials studyying Fabry's Disease.

Status	Trial	Sponsor	Phase
Completed	A Prospective Study to Investigate Safety and Tolerability of Shorter Infusion of Fabrazyme NCT06019728	Sanofi	Phase 4
Unknown	Early Detection and Follow-Up of Patients With Fabry's Disease NCT04847713	Hospital Clinico Universitario de Santiago	—
Completed	Evaluation of the Gastrointestinal Manifestation of Fabry's Disease NCT02798458	Massachusetts General Hospital	N/A
Terminated	Fabry's Disease and Pregnancy (PREFAB) NCT02582294	Groupe Hospitalier Diaconesses Croix Saint-Simon	—
Unknown	Impact of Enzyme Replacement Therapy on Cardiac Function in Patients With Fabry's Cardiomyopathy (RECAFTURE Tr NCT02469181	Yonsei University	—
Completed	Prevalence of Fabry's Disease in a Population of Patients With Chronic Pain NCT02450604	University Hospital, Bordeaux	N/A
Completed	The Efficacy and Safety of Switch Between Agalsidase Beta to Agalsidase Alfa for Enzyme Replacement in Patient NCT01268241	CENTOGENE GmbH Rostock	—
Completed	Prevalence of Fabry's Disease in a Population of Patients With Chronic Pains NCT01178164	University Hospital, Bordeaux	N/A
Completed	Analysis of the Nervous System in Patients With Fabry's Disease NCT00001491	National Institute of Neurological Disorders and Stroke (NINDS)	—